𝐂𝐡𝐨𝐨𝐬𝐢𝐧𝐠 𝐭𝐡𝐞 𝐑𝐢𝐠𝐡𝐭 𝐑𝐍𝐀-𝐒𝐞𝐪 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞 💡 Total RNA-Seq for regulatory RNA insights? mRNA-Seq to analyze gene expression? Understanding your research goals is key to unlocking the full potential of RNA sequencing. 🔗 Learn more about the right technique for your research: https://lnkd.in/eSw7XeVY #RNATechniques #Sequencing #OmicsResearch #OmicsSolutions
OHMX.bio
Biotechnology Research
Ghent, Flemish Region 1,640 followers
Your partner for Innovative OMICS solutions - Sequencing CRO determined in delivering Quality, Guidance and Science
About us
OHMX.Bio provides a complete R&D platform to help customers resolve their biological questions through cutting-edge technologies in different -omics fields: (epi)genomics, transcriptomics, translatomics and proteomics. Current flagships in portfolio are ribosome profiling and third generation sequencing. With its in-house developed high performant ribosome profiling service, OHMX.bio provides a genome-wide assessment of mRNA targeted by translating ribosomes. This highly sensitive sequencing-based technology unravels the translatome, a snapshot of RNA that is being translated. Quantification of gene-specific translation, discovery of non-canonical translation events, investigation of ribosome elongation speed and pausing, figuring out translation regulation by microRNAs and RNA-binding proteins and/or determination of mechanisms related to translation initiation and termination, are made possible. OHMX.bio also services third generation sequencing workflows based on the Oxford Nanopore Technology. Direct DNA and RNA solutions allow for amplification-free sequencing of (ultra-)long reads and additionally allow to map their epigenetic features. Applications are everywhere, in the fields of clinical and more specifically cancer research, environmental and plant research, microbiology and microbiome analysis, genome and transcriptome research.
- Website
-
https://ohmx.bio
External link for OHMX.bio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Ghent, Flemish Region
- Type
- Privately Held
- Founded
- 2019
- Specialties
- ribosome profiling service, RIBO-seq service, third generation sequencing, translatomics, transcriptomics, genomics, epigenomics, epitranscriptomics, bioinformatics, Oxford Nanopore Technology, direct RNA sequencing, direct DNA sequencing, metatranscriptomics, metagenomics, microbiome, sequencing, expression analysis, biologics, Long-read Sequencing, Quality, Custom, and Therapeutics
Products
Locations
-
Primary
Proeftuinstraat 86
Ghent, Flemish Region 9000, BE
Employees at OHMX.bio
Updates
-
As we reflect on the achievements of the past year, we are filled with gratitude for our incredible 𝐭𝐞𝐚𝐦, 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬, and 𝐜𝐥𝐢𝐞𝐧𝐭𝐬 who have helped make 2024 a year of growth and innovation. The work we do in the world of 𝐨𝐦𝐢𝐜𝐬 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 is only possible because of the collaboration and trust we share with all of you. Looking ahead to 2025, we are excited to continue pushing boundaries, fostering innovation, and contributing to the advancement of life sciences through 𝐜𝐮𝐭𝐭𝐢𝐧𝐠-𝐞𝐝𝐠𝐞 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬. Together, we will make an even greater impact on research and discovery! We wish you and your loved ones a 𝐣𝐨𝐲𝐨𝐮𝐬 𝐡𝐨𝐥𝐢𝐝𝐚𝐲 𝐬𝐞𝐚𝐬𝐨𝐧 and a 𝐩𝐫𝐨𝐬𝐩𝐞𝐫𝐨𝐮𝐬 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫! 🎉 Here’s to another year of 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 and 𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬! 🚀 #HappyHolidays #HappyNewYear #OmicsSolutions #LifeSciences #OmicsResearch
-
📢 𝐀 𝐍𝐞𝐰 𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝐟𝐨𝐫 𝐎𝐇𝐌𝐗.𝐛𝐢𝐨! Last month, we moved into anacura'𝐬 𝐬𝐭𝐚𝐭𝐞-𝐨𝐟-𝐭𝐡𝐞-𝐚𝐫𝐭 𝐨𝐟𝐟𝐢𝐜𝐞𝐬 and 𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬, a space that fosters collaboration and innovation. This move also brings us closer to our colleagues at AnaBioTec and Labo Nuytinck of the anacura group, enhancing opportunities for 𝐜𝐫𝐨𝐬𝐬-𝐝𝐢𝐬𝐜𝐢𝐩𝐥𝐢𝐧𝐚𝐫𝐲 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 and knowledge exchange within the group. This transition strengthens our capabilities and opens new doors to deliver 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐨𝐦𝐢𝐜𝐬 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 for our clients. Here’s to new beginnings and even greater opportunities to 𝐚𝐝𝐯𝐚𝐧𝐜𝐞 𝐜𝐮𝐭𝐭𝐢𝐧𝐠-𝐞𝐝𝐠𝐞 𝐨𝐦𝐢𝐜𝐬 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 and make a meaningful impact on the 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲! 🚀 #LifeSciences #Innovation #OmicsSolutions #anacura #OHMXbio #OmicsResearch
-
Our CSO Gerben Menschaert represented OHMX.bio at the BePa Proteomics Meeting today. On top of all the interesting discussions on proteomics innovations, he also connected with Geert Van Raemdonck, a mass spec expert, and one of our new colleagues from AnaBioTec (anacura group)! #Proteomics #BePA #OmicsSolutions #OmicsResearch
Very interesting lineup of topics and talks at the BePa Proteomics meeting: - Immunopeptidomics - Single cell proteomics - Clinical proteomics - Unconventional proteomics - Computational proteomics Good to interact with the very knowledgeable proteomics community here in Ghent. Up to speed again! Bumped into my new colleague Geert Van Raemdonck here 😉
-
OHMX.bio has officially joined flanders.bio, a dynamic network fostering collaboration and innovation in the life sciences sector across Flanders. As a specialized CRO leveraging advanced -omics technologies, our membership strengthens our connection to a thriving community of biotechnology and R&D leaders. Through flanders.bio, we’re excited to 𝐞𝐱𝐩𝐚𝐧𝐝 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐨𝐮𝐫 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞 in areas like transcriptomics, proteomics, and epigenetics, driving impactful research and clinical advancements.
-
🌍 𝐖𝐨𝐫𝐥𝐝 𝐀𝐈𝐃𝐒 𝐃𝐚𝐲 𝟐𝟎𝟐𝟒 – Together, we can make a difference. At OHMX.bio, we recognize the importance of advancing research to fight global health challenges like 𝐇𝐈𝐕/𝐀𝐈𝐃𝐒. While our expertise lies in cutting-edge 𝐑𝐍𝐀 𝐬𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 and 𝐨𝐦𝐢𝐜𝐬 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬, we know these tools have the potential to transform our understanding of diseases, including HIV. 🔬 With innovations like 𝐑𝐍𝐀-𝐒𝐞𝐪 and 𝐫𝐞𝐚𝐥-𝐭𝐢𝐦𝐞 𝐬𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠, we’re ready to support projects that aim to unravel the molecular complexities of HIV and its impact on the human body. Collaboration and innovation will light the way forward. 💡 Let’s commit to progress, compassion, and shared responsibility in the 𝐟𝐢𝐠𝐡𝐭 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐀𝐈𝐃𝐒. #WorldAIDSDay #HIVResearch #InnovateForHealth #OmicsSolutions #PrecisionMedicine #OmicsResearch
-
Today, we’re at UZA in Antwerp for the International Symposium ‘Microbiome: From Benchtop to Bedside', connecting with scientists, clinicians, and industry leaders to dive deep into the latest advancements in microbiome research. This event is all about bridging lab discoveries with real-world clinical impact. Let’s advance microbiome science together! If you’re here, come say hello to Gerben and Joannes! #MicrobiomeResearch #ClinicalInnovation #OHMXbio #UZA
-
We will be attending the "Microbiome: From Benchtop to Bedside" symposium at UZA! On November 26th, we’ll be joining researchers, clinicians, and industry leaders in Antwerp to explore the latest advancements in microbiome science. This event highlights the transformative impact of microbiome research from lab studies to clinical applications, a mission we’re passionate about at OHMX.bio. https://lnkd.in/etmp7nY6 #MicrobiomeResearch #ClinicalInnovation #OmicsResearch #OmicsSolutions #UZA
-
We are featured in LatchBio's Omics Solution Provider landscape. Being part of this landscape highlights the work we’re doing to support the omics community with advanced, integrated solutions. Big thanks for including us! #OmicsResearch #OmicsSolutions
-
𝐇𝐈𝐑𝐈𝐍𝐆 - 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐢𝐧 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 Are you passionate about cutting-edge sequencing technology and analytical precision? We are looking for a skilled professional to support innovative pharmaceutical projects, focusing on high-quality NGS data analysis. If you have a background in molecular biology, genetics, or biochemistry and want to contribute to meaningful research, this opportunity is for you! Learn more and apply here: https://lnkd.in/gmfFsjHc #Careers #NextGenSequencing #PharmaceuticalResearch #OmicsResearch #OmicsSolutions #JobListing #BioTech
Job opportunity - Pharmaceutical Analyst Next Generation Sequencing | OHMX.bio
https://ohmx.bio